SpiroChem AG, a Swiss fine chemicals company, headquartered in Basel, announced their partnership with BaseLaunch, the Basel Area-based incubator and accelerator that helps scientists and entrepreneurs launch exceptional biotech companies.
“We are very excited to partner with SpiroChem such that our portfolio companies can gain access to highest quality medical chemistry expertise and support! And at the same time, working with people that truly understand first-hand what it means to start a new company.”, said Stephan Emmerth, Director Business Development & Operations on the partnership.
With their cutting-edge know-how in drug design and can-do attitude when facing complex challenges in drug discovery, SpiroChem brings an added value to BaseLaunch’s portfolio companies and other life sciences ventures in the local ecosystem. Beyond a very innovative portfolio of products, SpiroChem supports ventures with lead optimization programs to improve ADME properties of drug candidates or to enter into new chemical space and secure/strengthen their IP positions. The company also has a track record of success for developing new synthetic strategies that can deliver larger quantities of development candidates.
SpiroChem is a best-in-class chemistry R&D company in the CRO sector, with world-leading expertise on the concept of bio-isosterism and the partner of choice for pharmaceutical, agrochemical, and life science companies. Their clients are located worldwide and include both large pharma and biotechs. SpiroChem has a track record of success at delivering solutions with a leading position in the design, synthesis, production, and commercialization of novel building blocks for use in drug discovery. Their team is comprised of leading scientists, experts in natural products synthesis, methodology, catalysis, chemical biology, and medicinal chemistry.
“It is great to see how vibrant the biotech scene in Switzerland has become in just a few years and BaseLaunch are doing a great job at supporting entrepreneurs and attract talents/projects to Basel. We are thrilled that SpiroChem is part of the equation and we will support BaseLaunch in their mission to build one of the world-leading biotech hubs” said Thomas Fessard, CEO of SpiroChem.